Technology & AI

Google DeepMind's Antigravity platform finds antimicrobial peptide candidate

Google DeepMind's Antigravity platform, using its Cheminformatics Skills, searched compounds and proposed novel rigidified macrocycles for drug discovery.

By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .

This story is no longer being updated. It reflects reporting up to .

What happened

Google DeepMind's Antigravity platform, using its Cheminformatics Skills, searched compounds and proposed novel rigidified macrocycles for drug discovery. The platform linked more than 30 scientific databases and identified a new antimicrobial peptide candidate. The candidate showed promising activity against a respiratory pathogen, but physical experiments have not yet confirmed it.

Why it matters

The candidate is now in wet-lab validation, the next step in testing whether it works. The reports describe the work as accelerating drug discovery workflows.

Timeline

  1. Nov 3, 10:00 AM ET: Google described how Antigravity and its Cheminformatics Skills speed up compound search and macrocycle design.
  2. Nov 3, 6:08 PM ET: The antimicrobial peptide candidate showed promising activity against a respiratory pathogen, though physical experiments have not confirmed it.

Coverage

More from Technology & AI

All Technology & AI news · Technology & AI story archive